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ABSTRACT: A variety of pathogenic bacteria can infect humans,
and rapid species identification is crucial for the correct treatment.
However, the identification process can often be time-consuming
and depend on the cultivation of the bacterial pathogen(s). Here,
we present a stand-alone, enzyme-free, optical DNA mapping assay
capable of species identification by matching the intensity profiles
of large DNA molecules to a database of fully assembled bacterial
genomes (>10 000). The assay includes a new data analysis
strategy as well as a general DNA extraction protocol for both
Gram-negative and Gram-positive bacteria. We demonstrate that
the assay is capable of identifying bacteria directly from uncultured
clinical urine samples, as well as in mixtures, with the potential to
be discriminative even at the subspecies level. We foresee that the assay has applications both within research laboratories and in
clinical settings, where the time-consuming step of cultivation can be minimized or even completely avoided.
KEYWORDS: nanofluidics, optical DNA mapping, diagnostics, bacteria, UTI
Technological advances in the past decades have resultedin a variety of biodiagnostic tests that have improved the
way that infectious diseases are diagnosed and treated.1
Correct pathogen identification is of great importance to
improve patient outcomes and can also help in limiting the
spread of disease and in infection control.2 Traditionally, the
diagnosis of bacterial infections has relied on phenotypic
methods or techniques such as 16S rRNA gene sequencing and
MALDI-TOF mass spectrometry, both of which are either
expensive and/or require pathogen cultivation before anal-
ysis.3,4 Cultivation is a time-consuming and sometimes
troublesome task, as some bacteria are not easy to cultivate.5,6
Yet, most clinical laboratories still rely on phenotypic methods.
Advances in sequencing technologies have opened up for the
introduction of whole-genome sequencing (WGS) in health-
care.7 In the past decade, the use of WGS has started migrating
into public health practice with epidemiological associations of
nosocomial infections as one of the earliest applications.8 Even
if promising approaches exist,9 the extensive preparation
protocols including bacterial cultivation, in combination with
high costs and complex analysis, have hampered the
progression of sequencing-based methods into diagnostic
tools in clinical practice.10 There is, thus, a need for new,
faster, and less complicated diagnostics assays for the accurate
identification of bacteria.
Optical DNA mapping (ODM) is an umbrella term for
methods visualizing sequence-dependent patterns along
stretched, single DNA molecules, typically ranging from 100
kb to 1 Mb in size.11 Stretching of the DNA is traditionally
done either on modified glass surfaces12 or in nanofluidic
channels,13 where the latter allows for high throughput and
uniform stretching. Contrary to many forms of DNA
sequencing, ODM can analyze long, single DNA fragments
without the need for any prior DNA amplification. Multiple
labeling strategies for producing the sequence-specific patterns
have been developed, based either on enzymatic labeling14 or
modulating DNA binding affinity.15 While enzymatic labeling
requires extensive labeling schemes,14,16,17 including steps to
wash and remove unbound fluorophores, affinity-based
methods, such as competitive binding used here,18 offer a
simple approach for DNA labeling.
Even if previous efforts have been made to identify bacteria
using ODM,19−27 no general approach has been reported.
Overall, previous studies lack general applicability or stream-
lined workflows, and they rely on cultivated bacterial samples.
We present here a new, fast, cultivation-free bacterial
identification assay based on ODM that includes both a
novel DNA extraction protocol and a new data analysis
strategy. Compared to our previous study,19 the approach
presented here does not require any prior knowledge about the
Received: November 27, 2019
Published: April 15, 2020
Articlepubs.acs.org/journal/aidcbc
© 2020 American Chemical Society
1076
https://dx.doi.org/10.1021/acsinfecdis.9b00464
ACS Infect. Dis. 2020, 6, 1076−1084
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,


















































sample content, and the new extraction protocol is designed to
work for both Gram-positive and Gram-negative bacteria. The
new data analysis strategy is based on assessing the uniqueness
of each mapped DNA molecule, to determine the presence of a
bacterial species. As a result, the ODM assay, based on the
competitive binding of netropsin and YOYO-1 to DNA,18 is
capable of identifying bacterial species with high precision,
both in mixtures and in uncultivated urine samples. Also,
because our assay is based on the analysis of single bacterial
DNA molecules, we avoid potential errors induced by DNA
amplification.
■ RESULTS AND DISCUSSION
In this study, we demonstrate the applicability of affinity-based
ODM for identifying bacterial species from clinical isolates and
mixtures, as well as directly from uncultivated samples from
patients with urinary tract infections (Figure 1A). A strategy,
based on classic pulsed-field gel electrophoresis (PFGE)
embedding of intact bacteria in agarose plugs, was developed
to prepare long, intact DNA molecules from a variety of
bacteria for ODM analysis. Lysis of bacterial cells in the
agarose plugs was performed with a single-step combination of
lysozyme and lysostaphin to ensure lysis of both Gram-positive
and Gram-negative bacteria. Proteinase K treatment and
washing of the plugs ensured the removal of proteins and
cell debris while keeping the DNA as intact as possible. Release
of the long DNA fragments from the agarose plugs was done
by gentle enzymatic degradation of the agarose with agarase.28
All of the steps were optimized to reduce the time from patient
sample to pure DNA; the DNA purity was verified by standard
spectroscopic methods (Nanodrop and Qubit), and the quality
(i.e., the size of the extracted DNA molecules) was verified
during the nanofluidic experiments. In total, the incubation
times were shortened from 18 to 5 h with sufficient yield,
purity, and integrity of the DNA for the ODM method for all
of the tested bacterial species (see below). After preparation,
the principle of the DNA labeling is based on that netropsin,
which is a nonfluorescent molecule that binds specifically to
AT base pairs,29 blocks these sites from the fluorescent YOYO-
1, which renders an emission intensity profile where AT-rich
regions will appear dark and GC-rich regions will appear
bright.18,19
The method operates by classifying intensity profiles as
either discriminative or nondiscriminative on the species level
(Figure 1B). Discriminative profiles are experimental intensity
profiles where all high-quality matches against the reference
database are to a single species. The accuracy of the methods is
governed by three main parameters: Cdiff, Cthresh, and Lmin. In
short, Cdiff and Cthresh determine which matches against the
reference database are of sufficiently high quality, while Lmin
sets the minimum acceptable profile length (see Methods
section for full details). A low value of both Cthresh and Cdiff will
increase the fraction of intensity profiles that are classified as
discriminative, reducing the amount of required data (Figure
2A). However, the fraction of correct matches, i.e., discrim-
inative profiles matching to the correct species, will decrease,
increasing the risk for identifying the incorrect species (Figure
2B). On the other hand, a high value of both Cthresh and Cdiff
will increase the required amount of data, because a large
fraction of profiles will be discarded. The results showed that
Cthresh does not affect the performance of the method to a large
extent, unless it is set very high (Cthresh > 0.6). Because the
fraction of correct matches approaches 100% for Cdiff > 0.05
with Cthresh fixed to 0.5 (Figure 3A), we decided to use a Cdiff =
0.05 and Cthresh = 0.5 for all subsequent analyses in this study.
This maintained a high true positive rate, while not
significantly reducing the throughput of the assay. It should,
however, be noted that the choice of parameter values is
dependent on the type of sample analyzed. In this study, we
focused on human pathogens, which have an abundance of
genome sequence data available that was used to generate the
reference database of theoretical profiles. If the analyzed
samples contained rare or even unknown species that are not
well-represented in the reference database, more conservative
values of Cdiff and Cthresh would likely be necessary to avoid
false positives and achieve optimal performance.
The size of the DNA molecules and, accordingly, the
parameter Lmin, has a significant effect on the possibility to
discriminate between species. To find the lower limit of DNA
fragment size for which the ODM assay still functions reliably,
an in silico simulation was performed by randomly sampling
Figure 1. Schematic overview of the optical DNA mapping assay. (A)
Experimental outline. Bacteria are isolated and then lysed in agarose
plugs to extract large (>100 kb) DNA molecules. The DNA is labeled
with YOYO-1 and netropsin in a single step, creating a sequence-
specific intensity profile along the DNA. To record the intensity
profile, the DNA is confined in a nanofluidic channel and imaged
using a fluorescence microscope. The resulting experimental intensity
profiles are compared to a reference database, and the bacterial
species present in the sample are identified based on profiles that
match discriminatively to a single species in the database. (B) Data
analysis pipeline. The time-averaged kymographs are matched to the
reference database of theoretical intensity profiles generated from
complete bacterial genomes. For each experimental intensity profile,
the database matches are filtered as follows. First, short intensity
profiles are discarded (length < Lmin). Then, the highest-scoring
matches are selected (Cmax within the range max(Cmax) to max(Cmax)
− Cdiff), and if all of the highest-scoring matches match to a single
species, the intensity profile is classified as discriminative. Lastly,
discriminative intensity profiles with sufficiently high-scoring matches
(max(Cmax) > Cthresh) are reported back to the user. See Methods
section for details of how the parameter space of Lmin, Cdiff, and Cthresh
was explored, and see Figures 2 and 3 for the results.
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and cutting experimental profiles into fragments of lengths
100−600 pixels (approximately 50−300 kb, details in Methods
section). The results revealed that profiles as small as 250
pixels (approximately 125 kb) yield the same true positive rate
as that of longer fragments (Figure 3B). However, at even
shorter fragment lengths, the performance dropped consid-
erably. We, therefore, set the threshold for the minimum
allowed length of a profile, Lmin, to 250 pixels. Furthermore, the
percentage of molecules that were discriminative increased
steadily with fragment size. Hence, fewer profiles are needed to
make a reliable species identification, the longer the DNA
molecules are.
As a first validation of the assay, we analyzed the DNA
extracted from three different Escherichia coli (E. coli) isolates.
Examples of matches between individual experimental and
theoretical intensity profiles with a high degree of similarity
(Cmax > 0.8) are shown in Figure 4. The same three intensity
profiles are compared to their respective, best matching
theoretical intensity profile of a non-E. coli species in Figure S2
in the Supporting Information. For the three E. coli isolates, a
majority of the intensity profiles (77%) were discriminative,
and all of them matched correctly to E. coli, demonstrating a
high specificity.
To evaluate the applicability of the assay for different
bacterial species, five bacterial species relevant for urinary tract
infections, both Gram-negative and Gram-positive, were
analyzed: Klebsiella pneumoniae, Pseudomonas aeruginosa,
Proteus mirabilis, Staphylococcus aureus, and Staphylococcus
saprophyticus. For all of the species except S. saprophyticus, all
of the discriminative profiles identified the correct species
(Figure 5A). For S. saprophyticus, one of the seven
discriminative intensity profiles matched incorrectly to Vibrio
parahemolyticus. However, by requiring at least three
discriminative intensity profiles for a species to consider that
species present (details in Methods section), only the correct
species was identified for all five isolates. Importantly, the same
protocol for DNA extraction was used for both Gram-positive
and Gram-negative bacteria, which is very important when
analyzing unknown samples. Thus, these results demonstrate
that the assay is general and can be used for a wide variety of
bacterial species.
Because each DNA molecule is analyzed individually, the
assay is ideal for samples where multiple bacterial species are
Figure 2. Effect of Cdiff and Cthresh on data quality and quantity. Heat maps showing fraction (%) of profiles found to be discriminative out of the
total number of mapped molecules (A), and the true positive rate (TPR), i.e., the fraction (%) of the experimental profiles found to be
discriminative to the correct species, out of the total number of discriminative profiles (B), as a function of Cdiff and Cthresh.
Figure 3. Effect of Cdiff and fragment size on data quality and quantity. (A) Fraction (%) of experimental profiles found to be discriminative to the
correct species out of the total number of discriminative profiles (solid line, dark green), and the fraction (%) of molecules found to be
discriminative out of the total number of mapped molecules (dashed line, green), as a function of Cdiff (Cthresh fixed to 0.5). (B) The fraction (%) of
the experimental molecules found to be discriminative to the correct species out of the total number of discriminative molecules (solid line, dark
brown), and the fraction (%) of molecules found to be discriminative out of the total number of mapped molecules (dashed line, light brown), as a
function of fragment size (Cdiff = 0.05, Cthresh = 0.5). One pixel corresponds to approximately 500 bp.
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present. To illustrate this, five different mixes of bacteria were
analyzed, varying both in the number of different species, and
their ratios, and in the mixtures of Gram-positive and Gram-
negative bacteria. We successfully identified all of the bacterial
species present in all five mixes (Figure 5B), and only three
single intensity profiles were found to be discriminative to an
incorrect species. In the 25/25/25/25 mixture, one profile
matched discriminatively to Burkholderia stagnalis and one to
Corynebacterium diphtheriae, and in the 10/20/30/40 mixture,
one profile matched discriminatively to Campylobacter jejuni.
All of these incorrect species had no more than a single profile
that matched discriminatively to them. Hence, given the
threshold of at least three matching profiles, only the correct
bacterial species were reported for all of the mixed samples.
Due to multiple factors, the assay presented here is, in its
current form, not well suited to determine initial concen-
trations of bacteria in a sample or to specify ratios of bacteria in
mixtures. These factors include differences in DNA extraction
efficiency and genome size (a smaller genome yields a lower
relative DNA concentration), degree of AT/GC sequence
variation (resolution), and relative uniqueness of sequences in
the database. With this in mind, the experimental results
overlapped surprisingly well with the estimated ratios of
bacteria in the mixtures (Figure 5B), based on bacterial
concentration (CFU/mL). The results could potentially be
improved by calibrating the assay for different bacterial species.
Because the ODM assay is a single-molecule-based
technique, the amount of DNA needed to perform the analysis
is as low as 10 picomoles (concentration ≥500 nM (bp)), and
the amount of DNA used for the actual analysis is only
approximately 10 attomoles (bp). The small amount of sample
needed for analysis makes the method suitable for samples
with low concentrations of bacteria, such as clinical samples,
without the need to first cultivate the bacteria. As proof of
concept, DNA was extracted directly from three different
clinical urine samples from patients suffering from urinary tract
infections. Following cultivation, bacterial-species identifica-
tion was conducted with MALDI-TOF (Bruker Daltronics;
Bremen, Germany), and the initial bacterial concentration was
confirmed to be above 105 CFU/mL, which corresponds to the
limit for the significant growth of bacterial pathogens in urine.
Using the ODM assay, we were able to detect the correct
bacterial species in all three samples (Figure 6).
Importantly, potential contamination with human DNA
molecules does not affect the results, because any large
fragments of human DNA are unlikely to match discrim-
inatively to any bacterial species. With the highly sensitive
ODM assay, as with any culture-based method, there is a
possibility that contaminating bacteria will give rise to false
positive results. This is already a problem today in the clinical
setting when using urine cultures, as low-level contamination
with Gram-negative bacilli can complicate interpretation, along
with asymptomatic bacteriuria. The correct way of addressing
this issue is to focus on correct sampling and correct indication
for UTI diagnostics. Moreover, we foresee that, with further
optimized DNA extraction, the method could be used, for
Figure 4. Results for E. coli isolates. Example fits of experimental
intensity profiles (green) and their respective highest-scoring
theoretical intensity profile (black) for each of the three E. coli
isolates (sequence types 93, 10, and 131). The inner circle in the pie
charts illustrates the species distribution in the analyzed sample, and
the outer circle illustrates the obtained species distribution of the
discriminative profiles (the exact number of discriminative profiles
specified).
Figure 5. Results for single-species samples and bacterial mixtures. The results obtained from single-species samples (A) and mixed samples (B,
ratios specified beneath each chart), where each chart represents one sample. The inner circle illustrates the species distribution in the sample, and
the outer circle illustrates the obtained species distribution of the discriminative profiles (with the exact number of discriminative profiles specified).
Incorrect matches, i.e., profiles matching discriminatively to a species not present in the sample, are shown in gray.
Figure 6. Noncultured urine samples. The inner circle illustrates the
expected species distribution in each sample, and the outer circle
illustrates the obtained species distribution of the discriminative
profiles (the exact number of discriminative profiles indicated).
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example, to identify bacteria in positive blood culture bottles
and also, potentially, directly in cerebral spinal fluid.
Summarizing the data obtained for all of the samples of this
study, 36% (344 out of 944) of the mapped DNA molecules
were discriminative on the species level, and the remaining
data were not used for the species identification. Out of the
discriminative profiles, 99% (340 out of 344) matched the
correct species, and 4 matched an incorrect species. By
requiring a minimum of three discriminative profiles to
confidently report a species as present in a sample, we
achieved an accuracy of 100% for all of the samples. Even if
they are rare, it is important to understand why incorrect
discriminative matches appear. The fits between the four
incorrectly matched intensity profiles, and their respective
highest-scoring matches, show that they all have at least one
very dominating feature, combined with an overall low-
intensity variation across the profile, rendering a high Cmax
even if the overall fit is rather poor (Figure S3 in the
Supporting Information). The dominating features might, for
example, be a result of knots in the DNA molecules, leading to
local compaction of DNA and, thus, a brighter signal in these
areas.30 If needed, preprocessing of the experimental data
could potentially remove molecules displaying such features,
increasing the specificity of the assay even further.
Another possible reason for incorrect matches is errors in
the reference database, such as incorrect annotations or
contamination. It should be noted that, by increasing Cdiff to
0.06, all incorrect matches were removed at the cost of fewer
discriminative profiles. Importantly, even if we observed
incorrect matches, we never had more than a single match
to an incorrect species, making the incorrect matches easy to
distinguish and discard. By requiring at least three profiles for
the identification of a species, we achieved a correct species
identification in all of the analyzed samples.
The vast majority of all of the mapped DNA molecules were
>250 kb, with an average size of ∼350 kb. The fact that DNA
molecules as short as ∼125 kb can be used to identify bacteria
correctly, as shown in Figure 3B, is important. This means that
it will also be possible to identify bacteria in samples where the
DNA is significantly more fragmented than those in this study.
Increased fragmentation can occur in dead bacteria and when
using more harsh extraction protocols, for example, to speed
up the assay even further.
We finally investigated the potential of using the mapped
intensity profiles to discriminate also at the subspecies level by
identifying the sequence type (ST) of three of the previously
analyzed E. coli isolates. This is of high relevance as some STs,
such as E. coli ST 131,31 display epidemic occurrence and,
therefore, are clinically important to detect, not the least in
complex microbial communities. We used the same method to
determine whether the profiles were also discriminative on the
sequence type level. Using the same parameter values, we were
able to indicate the correct sequence types of all of the three
isolates (Figure 7). We, therefore, foresee that, in the future, it
should be possible to use the mapped intensity profiles to not
only resolve the species of a present bacterium but also access
subspecies information, such as clonal complexes and
phylogroups. Moreover, plasmids, which are already present
in the DNA extraction, could be mapped in the same
experiment, enabling plasmid tracing in outbreak situations
or resistance genes detection, as we have previously
demonstrated in several different studies.32−38
To conclude, we have developed an affinity-based ODM
assay capable of identifying bacteria with very high precision,
not only in single cultures but also in mixtures, as well as
directly in clinical urine samples. The presented DNA
extraction protocol is general and works for both Gram-
negative and Gram-positive bacteria. Moreover, our results
suggest that the highly specific intensity profiles generated with
the ODM assay, together with our new data analysis strategy,
have the potential to be discriminative even at the subspecies
level. At present, the lead time from the urine sample to the
result is down to 8 h, and we anticipate that this can be
substantially reduced when the process is fully automated. We
foresee that the assay could have applications both within
research laboratories as well as in clinical settings, where this
methodology could complement time-consuming, cultivation-
based methods.
■ METHODS
Bacterial Samples. The bacteria used in the study were
selected based on clinical relevance; for details see Table S1 in
the Supporting Information. For the cultivated bacterial
samples, the strains were stored in 10% DMSO stocks at
−80 °C, plated on Luria−Bertani (LB) agar plates with 1.5%
agar, and later grown in LB broth at 37 °C before DNA
isolation. Mixes of strains were prepared in the same manner
by growing separate cultures overnight and mixing relative
amounts of each strain to achieve the selected ratios before
DNA isolation. The noncultivated urine samples were
collected at the Karolinska University Hospital in Stockholm
and used directly for DNA isolation. Pseudoanonymized
samples were shared with the researchers carrying out the
ODM experiments, without sharing the key making patients
identifiable. No informed consent was collected from patients,
as per the ethical committee assessment (recordal 2018/2735-
31/2).
DNA Isolation. The method used for DNA extraction was
designed to obtain large-sized (>100 kb) DNA molecules for
subsequent labeling and analysis. The DNA extraction was
initially performed by method i, CHEF Genomic DNA kit
from BIO-RAD, and later by method ii, a tailor-made
extraction protocol, inspired by the work of Matushek et
al.39 In short, for method i, an overnight culture of the bacteria
was diluted 100-fold and allowed to grow until it reached an
OD600 of 0.8−1.0. For each milliliter of agarose plugs, 5 × 108
cells were centrifuged. For the noncultivated samples, 1−3 mL
of urine was centrifuged. The bacterial pellet was resuspended
in a cell suspension buffer, combined with 2% CleanCut
agarose (50 °C), and cast into plug molds. The plugs were
Figure 7. Results from the subspecies identification of the E. coli
isolates. The inner circle in the pie charts illustrates the expected
distribution of E. coli sequence types in each sample, and the outer
circle illustrates the obtained distribution of profiles discriminative on
the sequence type level (with the exact number of discriminative
profiles specified). Note that only one discriminative fragment was
obtained for the E. coli isolate belonging to ST10. This is below the
required threshold of three discriminative fragments used at the
species level.
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incubated in lysozyme buffer for 2 h at 37 °C, rinsed with
sterile water, and incubated overnight in Proteinase K reaction
buffer at 50 °C. The next day, the plugs were washed four
times for 1 h in a 1× wash buffer at room temperature with
gentle agitation. The plugs were stored in wash buffer at 4 °C
until further use. For this method, all of the buffers used were
premade by the kit manufacturer (BIO-RAD). For method ii,
250 μL of overnight culture or 1−3 mL of a noncultivated
urine sample was spun down and the pellet was resuspended in
50 μL of 2× lysis buffer (1× lysis buffer = 6 mM Tris HCL pH
7.4, 1 M NaCl, 10 mM EDTA pH 7.5, 0.5% Brij, 0.2%
deoxycholate, and 0.5% sodium lauryl sarcosine), with 1 mg/
mL lysozyme, 20 mg/mL RNase A, and 100 μg/mL
lysostaphin added fresh on the day of the experiment; this
was mixed with 50 μL of 1.6% low-melting-point agarose (50
°C) and allowed to solidify in a plug mold. The plug was
incubated in 300 μL of 1× lysis buffer at 37 °C for 2 h. Next,
the plug was incubated in 300 μL of EPS solution (10 mM Tris
HCL pH 7.4, 1 mM EDTA), including 100 μg/mL proteinase
K and 1% sodium dodecyl sulfate, which was added fresh on
the day of the experiment, at 50 °C for 1 h. Finally, all of the
residual EPS solution was discarded, and the plug was
incubated in TE buffer (10 mM Tris HCL pH 7.4, 0.1 mM
EDTA) at 50 °C for 1 h before storage at 4 °C. Method ii is
effective for both Gram-negative and Gram-positive bacteria
and reduces the overall time for DNA extraction by almost a
factor of five. There was no notable difference in the quality of
the extracted DNA when using extraction methods i or ii.
The agarose plugs (100 μL) were melted in 20 μL of 10×
CutSmart Buffer (New England Biolabs) and 78 μL of MQ-
water at 70 °C for 10 min, followed by incubation at 42 °C for
10 min, prior to the addition of 2 μL of agarase (ThermoFisher
Scientific, 0.5 U/L) and a second incubation at 42 °C for at
least 1 h. The DNA concentration was determined using a
Qubit Fluorometer 2.0 (ThermoFisher Scientific).
Sample Preparation and Nanofluidic Experiments.
The sequence-based intensity profiles for the ODM experi-
ments were created by the addition of YOYO-1 (excitation of
491 nm/emission of 509 nm, Invitrogen) and netropsin
(Sigma-Aldrich).18 A 0.5× TBE (Tris-Borate-EDTA, Medi-
cago, 10 μL) solution was prepared with 1 μM (base pairs)
extracted bacterial DNA, 1 μM (base pairs) λ-DNA (included
as an internal size reference, 48 502 bp, Roche Biochem
Reagents), 0.2 μM YOYO-1 (ratio of DNA/YOYO is 10:1),
and 60 μM netropsin (ratio of netropsin/YOYO is 300:1),
followed by incubation at 50 °C for 30 min. Next, the DNA
solution was diluted by a factor of 10 with 88 μL of MQ-water
and 2 μL of β-mercaptoethanol (used to prevent photo-
damaging, Sigma-Aldrich), obtaining a final buffer concen-
tration of 0.05× TBE.
To record the intensity profiles, the DNA fragments were
confined in nanofluidic channels and imaged using a
fluorescence microscope. The nanofluidic experiments were
performed using 500 μm long nanochannels with a cross
section of 100 × 150 nm2 (height × width) (see Figure S1 in
the Supporting Information), fabricated in silica utilizing
standard methods.40 The nanochannels were spanned by two
microchannels, which were connected to two loading wells
each. For each sample, 10 μL (1 picomole, 100 nM, bacterial
DNA) of the prepared DNA sample was loaded onto the chip,
and the DNA was forced into the nanochannels using pressure-
driven N2 flow. The DNA was imaged using a fluorescence
microscope (Zeiss AxioObserver.Z1) equipped with a 63×
(1.6× optovar) oil immersion objective (NA = 1.46, Zeiss) and
an Andor iXon EMCCD camera. For each DNA molecule, 50
frames were acquired using 100 ms exposure.
Data Analysis. The processing of output data from the
nanofluidics-based ODM fluorescence imaging experiments
was divided into three main parts: (i) generation and time
averaging of kymographs to generate intensity profiles, (ii)
comparison of the experimental intensity profiles to a reference
database of theoretical intensity profiles, and (iii) identification
of intensity profiles that were discriminative on the species
level (Figure 1B).
The first part converts an imaging output (movie of up to 50
time frames) to a kymograph, the steps for which are explained
in detail in the Supporting Information of a previous study.28
The kymographs were used to generate time averages
(intensity profiles). In the second part, all of the experimental
intensity profiles from a sample were compared with a
reference database of theoretical intensity profiles. The
database was based on all of the complete bacterial genomes
in RefSeq (as of October 16, 2018), excluding sequences
shorter than 500 kb or with the word “plasmid” in their
FASTA headers. In total, the resulting reference database
consisted of theoretical intensity profiles based on 10 310
sequences belonging to 2355 different bacterial species.
Theoretical intensity profiles were generated as described in
a previous study41 and stretched to the measured nanometer/
base pair ratio, as described previously.28 In the comparison,
each experimental intensity profile, i, was matched against each
theoretical intensity profile, j, using every possible start
position, k, in the theoretical profile, and match scores, Ci,j,k,
were calculated using the Pearson correlation coefficient. For
each combination of experimental and theoretical intensity
profiles, the following information was saved for the highest-
scoring match: match score (max
k
Ci,j,k = Cmax), start position in
the theoretical profile (k), length of the experimental profile,
and stretch factor.
In the third part (Figure 1B), the Cmax scores were used to
identify intensity profiles that were discriminative on the
species level in the following way. The analysis results depend
on the settings of three parameters, which are described below:
Cdiff, Lmin, and Cthresh. First, all of the experimental intensity
profiles shorter than a set threshold, Lmin, were removed from
further analysis. Then, considering one experimental intensity
profile at the time, we identified high-quality matches against
the reference database by discarding all of the matches against
theoretical intensity profiles with a Cmax score more than the
Cdiff value lower than the theoretical intensity profile with the
highest score (max
j k,
Ci,j,k). Next, an experimental profile was
classified as discriminative at the species level if the following
two criteria were met: (a) all remaining high-quality matches
were against theoretical profiles belonging to a single species
and (b) the best match had a Cmax score above a set threshold,
Cthresh. From a set of experimental profiles, the species
distribution of the discriminative profiles was reported. All of
the other profiles were discarded as they were classed as
noninformative.
Because there is a risk for false positives, i.e., intensity
profiles that are discriminative but to an incorrect species, a
threshold was implemented for the minimum number of
intensity profiles required before confidently identifying a
bacterial species as present in a sample. Out of all of the DNA
molecules mapped in this study, only 0.4% were classified as
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false positives. By requiring at least three intensity profiles that
are discriminative to the same species to identifying the species
as present, the average number of mapped DNA molecules
required to state the presence of an incorrect species in the
sample, under the assumption of independence, is approx-
imately 100 000. To set a strict threshold, considering that
typically fewer than 100 DNA molecules were mapped per
isolate in this study, any identification of a species by fewer
than three discriminative profiles was deemed unreliable.
To test the effect of different parameter values, the true
positive rate, i.e., the proportion of the discriminative profiles
that were discriminative to the correct species, as well as the
proportion of discriminative profiles out of all of the measured
profiles, was tested using different values of the parameters Cdiff
(range 0.01−0.1, step length 0.01) and Cthresh (range 0.3−0.7,
step length 0.05). One sample for each of the species included
in this study was used for the parameter evaluation to avoid
any species-specific bias: isolates EC3, KP1, PA1, PM1, SA,
and SS (see Table S1 in the Supporting Information).
To evaluate the sensitivity of the assay to the size of the
DNA molecules and, by extension, the effect of the Lmin
parameter, experimental intensity profiles were randomly cut
in silico into fragments of a specified length using the same
samples as those used for the parameter evaluation. We
generated fragments of lengths 100−600 pixels, in 50-pixel
intervals. To generate the fragments, we used bootstrapping,
i.e., random sampling with replacement, by first counting the
number of possible fragments, Ki, for each intensity profile.









. We used MATLAB’s command
randsample() to pick an experimental profile i from this
probability. Finally, a subsample of the specified length from
the randomly drawn intensity profile was randomly selected
based on a uniform distribution [MATLAB’s randi()]. For
each included sample and fragment length, a set of 100 (not
necessarily distinct) fragments was generated. The cut
fragments were analyzed in terms of the true positive rate
and the proportion of discriminative profiles using the




The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acsinfecdis.9b00464.
Overview of bacterial isolates, schematic overview of the
design of the nanofluidic chip, best match of non-E. coli
species, and fits of intensity profiles that match
discriminatively to incorrect species (PDF)
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